<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.2minutemedicine.com/feed/</title><link>https://www.2minutemedicine.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Sat, 31 May 2025 02:25:01 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Personalized visual perceptual learning digital therapy may improve vision post-stroke</title><link>https://www.2minutemedicine.com/personalized-visual-perceptual-learning-digital-therapy-may-improve-vision-post-stroke/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2019/10/stroke-PD-300x150.jpg</image_url><description>1. In this multicenter randomized controlled trial, a 12-week personalized visual perceptual learning (VPL) program significantly improved visual fiel...</description><pubDate>Sat, 31 May 2025 00:00:56 GMT</pubDate></item><item><title>Delayed alteplase has clinical benefits in posterior circulation stroke outcomes</title><link>https://www.2minutemedicine.com/delayed-alteplase-has-clinical-benefits-in-posterior-circulation-stroke-outcomes/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2015/01/index-300x151.jpg</image_url><description>1. In this randomized controlled trial of patients with posterior circulation stroke not for thrombectomy, treatment with alteplase 4.5 to 24 hours af...</description><pubDate>Fri, 30 May 2025 21:00:13 GMT</pubDate></item><item><title>#VisualAbstract: Methotrexate is Noninferior to Prednisone in the Treatment of Pulmonary Sarcoidosis</title><link>https://www.2minutemedicine.com/visualabstract-methotrexate-is-noninferior-to-prednisone-in-the-treatment-of-pulmonary-sarcoidosis/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2025/05/2MM_05.19.25_Astrid_1_PulmonarySarcoidosis-300x300.jpg</image_url><description>Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent...</description><pubDate>Fri, 30 May 2025 15:00:30 GMT</pubDate></item><item><title>#VisualAbstract: Tolebrutinib Reduced Disaibility Progression in Nonrelapsing Secondary Progressive Multiple Sclerosis</title><link>https://www.2minutemedicine.com/visualabstract-tolebrutinib-reduced-disaibility-progression-in-nonrelapsing-secondary-progressive-multiple-sclerosis/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2025/05/2MM_VA_20may2025_2-300x300.jpg</image_url><description>Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent...</description><pubDate>Fri, 30 May 2025 15:00:05 GMT</pubDate></item><item><title>Pulsed field ablation noninferior to cryoablation for reducing paroxysmal atrial fibrillation recurrence</title><link>https://www.2minutemedicine.com/pulsed-field-ablation-noninferior-to-cryoablation-for-paroxysmal-atrial-fibrillation/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2015/12/heart2_edited_pd-300x150.jpg</image_url><description>1. In this randomized controlled trial of patients with symptomatic paroxysmal atrial fibrillation, pulsed field ablation (PFA) was noninferior to cry...</description><pubDate>Fri, 30 May 2025 13:00:15 GMT</pubDate></item></channel></rss>